Home | Welcome to Contract Pharma   
Last Updated Friday, May 29 2015

Print

Search Results for 'Drug Development'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Contract Service Directory Categories

View All Categories »


Search Results:

Published May 29, 2015
Trexler and Su to lead commercial and medical strategy Read More »
Published May 29, 2015
Will utilize NanoString’s nCounter Analysis to optimize gene expression signatures Read More »
Published May 29, 2015
43,000 sq.-ft. headquarters in Shanghai now has approximately 300 employees Read More »
Published May 29, 2015
Will evaluate AZ’s investigational anti-PD-L1 with Lilly’s CYRAMZA Read More »
Published May 27, 2015
Bedford to bolster branding and marketing ops post Harlan acquisition Read More »
Published May 27, 2015
Aims to simplify patient randomization and clinical supply management Read More »
Published May 27, 2015
Provides access to Quintiles’ processes and platforms Read More »
Published May 27, 2015
To explore late-stage assets in combination with Imbruvica Read More »
Published May 27, 2015
Believes events of suicidal ideation and behavior likely to restrict labeling Read More »
Published May 22, 2015
Expands protein detection franchise Read More »
Published May 21, 2015
Selected for a highly specialized vaccine fill/finish project Read More »
Published May 21, 2015
Biomay to apply VTU Pichia strains for the production of recombinant allergens Read More »
Published May 20, 2015
Will use Achillion assets to develop pan-genotypic oral regimen for HCV Read More »
Published May 19, 2015
Will evaluate combinations of Advaxis’s Lm-LLO immunotherapy technology and Sorrento’s immunomodulatory antibodies Read More »
Published May 18, 2015
Phase I drug demonstrates oral bioavailability, target inhibition, safety and tolerability Read More »
Published May 18, 2015
Aims to target underlying causes of MS disease progression Read More »
Published May 15, 2015
Publishes results from Enabled-First-in-Human program conducted for the Janssen WAVE Early Development unit. Read More »
Published May 14, 2015
Biologics Services revenues up 75% in the quarter Read More »
Published May 14, 2015
Will combine biotech capabilities to develop therapies for autoimmune disorders Read More »
Published May 12, 2015
Will collaborate to identify and validate tumor targets and corresponding TCRs in cancer Read More »
Published May 12, 2015
Secures exclusive option to acquire the company following a Phase II trial of recAP Read More »
Published May 12, 2015
Gains leading biologic treatment and oncology infrastructure for $900M Read More »
Published May 11, 2015
Adds approximately 60 on-market products and nearly 70 R&D pipeline programs Read More »
Published May 11, 2015
Firms will co-develop Elasmogen's soloMER technology Read More »
Published May 11, 2015
Clinical research specialists Accenture, Aptus, Boyds and KJC bring strong experience to CTDs orphan drug program Read More »
Published May 8, 2015
Beeler brings15 years of experience in the life sciences Read More »
Published May 8, 2015
Additional 27,000 sq.-ft. will supply materials for clinical trials Read More »
Published May 7, 2015
Will combine biotech capabilities to develop therapies for autoimmune disorders Read More »
Published May 6, 2015
Hare brings 28 years of experience in the biopharma and CROs industries Read More »
Published May 6, 2015
Expects revenues from device-enabled products to double by 2020 Read More »
Published May 6, 2015
Gains portfolio of histone demethylases for the treatment of certain cancers Read More »
CRO Outlook & Drug Development Trends
By Kristin Brooks , Contract Pharma
Published May 6, 2015
CRO industry grows as increasingly complex R&D trends demand advanced expertise Read More »
Published May 5, 2015
Will assume clinical development and commercialization of ISIS-FXIRx Read More »
Published May 5, 2015
Contract revenue up 47% in the quarter Read More »
Published May 5, 2015
Revenues up 72% in the quarter Read More »
Published May 1, 2015
Validates undisclosed target to treat a neurological disorder Read More »
Published April 28, 2015
Specialty Injectable Pharmaceuticals up 13% Read More »
Published April 23, 2015
Will initiate a GLP toxicity study Read More »
Published April 23, 2015
Initiates Phase III Trial Read More »
Published April 20, 2015
Will evaluate birinapant in combination with KEYTRUDA in solid tumors Read More »
Published April 17, 2015
Samcyprone used for the treatment of malignant melanoma stage IIb to IV Read More »
Published April 16, 2015
Reicin brings extensive research and leadership experience Read More »
Published April 16, 2015
Aims to accelerate clinical trial processes Read More »
Published April 16, 2015
Will conduct combination trails in melanoma Read More »
Published April 15, 2015
Will provide discovery and development services from gene to candidates and beyond Read More »
Published April 15, 2015
Alliance expanded to include select pre-commercialization activities Read More »
Published April 15, 2015
Plans to progress development candidate through IND-enabling studies Read More »
Published April 14, 2015
Batra to lead the combined life science business Read More »
Published April 14, 2015
Will partner to develop new compounds Read More »
Published April 14, 2015
Clinical ops to occupy 9,000 sq. ft. facility by mid-2015 Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On